Skip to main content
Tine Gadegaard Hindso on Muck Rack

Tine Gadegaard Hindso

As seen in: Nature, American Journal of Ophthalmology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tine Gadegaard

Contact Tine Gadegaard, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma - Scientific Reports

|
By Tine Gadegaard Hindso, Torben Martinussen, Annika Loft, Kristoffer Nissen, Carsten Faber, Marco Donia, Inge Marie Svane, Eva Ellebaek, Jens Folke Kiilgaard, Sune Høgild Keller, Mette Bagger Sjøl
| Nature Verified
Abstract The prognostic value of metabolic tumor burden parameters obtained from 18F-FDG PET/CT imaging was evaluated in this retrospective national multicenter study of patients with metastatic posterior uveal melanoma (PUM) and compared to the largest diameter of the largest metastatic lesion (LDLM) and the American Joint Committee on Cancer (AJCC) staging system.
Open in Who Shared Issue with article?

Lymphoma of the Lacrimal Gland - An International Multicenter Retrospective Study

|
By Peter Rasmussen Verified, Lauge Hjorth Mikkelsen, Tine Gadegaard Hindso, Marina K.H. Knudsen
| American Journal of Ophthalmology Verified
Highlights • The distribution of lymphoma subtypes resembles that of the ocular adnexa. • The most frequent lymphoma subtypes are extranodal marginal zone B-cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma. • Lacrimal gland lymphoma has an overall 5-year disease-specific survival of 87.5%. • Lymphoma subtype is a significant predictor of disease-specific survival.
Open in Who Shared Issue with article?
See all 2 articles